These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38758549)

  • 1. Urine-Based Test Could Help Identify Aggressive Prostate Cancer.
    Harris E
    JAMA; 2024 Jun; 331(22):1883. PubMed ID: 38758549
    [No Abstract]   [Full Text] [Related]  

  • 2. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
    McKiernan J; Donovan MJ; Margolis E; Partin A; Carter B; Brown G; Torkler P; Noerholm M; Skog J; Shore N; Andriole G; Thompson I; Carroll P
    Eur Urol; 2018 Dec; 74(6):731-738. PubMed ID: 30237023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond prostate-specific antigen - future biomarkers for the early detection and management of prostate cancer.
    Killick E; Bancroft E; Kote-Jarai Z; Eeles R
    Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):545-55. PubMed ID: 22682955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary glycoproteins associated with aggressive prostate cancer.
    Dong M; Lih TM; Chen SY; Cho KC; Eguez RV; Höti N; Zhou Y; Yang W; Mangold L; Chan DW; Zhang Z; Sokoll LJ; Partin A; Zhang H
    Theranostics; 2020; 10(26):11892-11907. PubMed ID: 33204318
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.
    Tosoian JJ; Trock BJ; Morgan TM; Salami SS; Tomlins SA; Spratt DE; Siddiqui J; Kunju LP; Botbyl R; Chopra Z; Pandian B; Eyrich NW; Longton G; Zheng Y; Palapattu GS; Wei JT; Niknafs YS; Chinnaiyan AM
    J Urol; 2021 Mar; 205(3):732-739. PubMed ID: 33080150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X; Foj L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
    McKiernan J; Donovan MJ; O'Neill V; Bentink S; Noerholm M; Belzer S; Skog J; Kattan MW; Partin A; Andriole G; Brown G; Wei JT; Thompson IM; Carroll P
    JAMA Oncol; 2016 Jul; 2(7):882-9. PubMed ID: 27032035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
    Zhao F; Olkhov-Mitsel E; Kamdar S; Jeyapala R; Garcia J; Hurst R; Hanna MY; Mills R; Tuzova AV; O'Reilly E; Kelly S; Cooper C; ; Brewer D; Perry AS; Clark J; Fleshner N; Bapat B
    Clin Epigenetics; 2018 Nov; 10(1):147. PubMed ID: 30470249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population.
    Wei HM; Chen HT; Wang P; Wu YS; Na R; Liu F; Sun JS; Jiang DK; Lu DR; Xu J
    Asian J Androl; 2015; 17(1):168-70. PubMed ID: 25412674
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer: improving PSA testing by adjusting for genetic background.
    Scardino PT
    Nat Rev Urol; 2013 Apr; 10(4):190-2. PubMed ID: 23419491
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
    Tosoian JJ; Zhang Y; Xiao L; Xie C; Samora NL; Niknafs YS; Chopra Z; Siddiqui J; Zheng H; Herron G; Vaishampayan N; Robinson HS; Arivoli K; Trock BJ; Ross AE; Morgan TM; Palapattu GS; Salami SS; Kunju LP; Tomlins SA; Sokoll LJ; Chan DW; Srivastava S; Feng Z; Sanda MG; Zheng Y; Wei JT; Chinnaiyan AM;
    JAMA Oncol; 2024 Jun; 10(6):726-736. PubMed ID: 38635241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genetic biomarkers in urine for early detection of prostate cancer.
    Kavalci E; Onder AU; Brusgaard K; Bostanci A; Selhanoglu MY; Serakinci N
    Curr Probl Cancer; 2021 Feb; 45(1):100616. PubMed ID: 32660704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.
    Helfand BT; Conran CA; Xu J; Catalona WJ
    Curr Opin Urol; 2017 Sep; 27(5):475-480. PubMed ID: 28614085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
    Fredsøe J; Rasmussen AKI; Mouritzen P; Borre M; Ørntoft T; Sørensen KD
    Int J Cancer; 2019 Nov; 145(9):2558-2567. PubMed ID: 30903800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone.
    Kang HW; Lee HY; Byun YJ; Jeong P; Yoon JS; Kim DH; Kim WT; Kim YJ; Lee SC; Yun SJ; Kim WJ
    Investig Clin Urol; 2020 Jul; 61(4):411-418. PubMed ID: 32665998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contemporary markers and histological features of prostate cancer].
    Vasilyev AO; Prilepskaya EA; Kovylina MV; Govorov AV; Sadchenko AV; Sidorenkov AV; Pushkar DY
    Urologiia; 2016 Dec; (6):164-166. PubMed ID: 28248064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer.
    Nilsson J; Skog J; Nordstrand A; Baranov V; Mincheva-Nilsson L; Breakefield XO; Widmark A
    Br J Cancer; 2009 May; 100(10):1603-7. PubMed ID: 19401683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis: Proportionate response.
    DeWeerdt S
    Nature; 2015 Dec; 528(7582):S124-5. PubMed ID: 26672783
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
    Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
    PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.